Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Triethylamine → ethyl {4-[(2-{7-[(2-thienylsulfonyl)amino]-1H-indol-2-yl}-1,3-thiazol-5-yl)methyl]piperazin-1-yl}acetate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | Ammonium Chloride | HCID 25517 | — |
| 반응물 | Ethyl piperazine-1-acetate | HCID 207112 | — |
| 반응물 | HCID 57476122 | HCID 57476122 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | ethyl {4-[(2-{7-[(2-thienylsulfonyl)amino]-1H-indol-2-yl}-1,3-thiazol-5-yl)methyl]piperazin-1-yl}acetate | HCID 59136017 | 83% |
반응 단계
To a solution of N-{2-[5-(chloromethyl)-1,3-thiazol-2-yl]-1H-indol-7-yl}thiophene-2-sulfonamide (0.460 g) in N,N-dimethylformamide (12 ml) were added ethyl piperazin-1-ylacetate (0.385 g) and triethylamine (0.31 ml), and the mixture was stirred at room temperature for 15 hr. Saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The extract was washed successively with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was recrystallized from tetrahydrofuran-hexane to give the title compound (0.507 g, yield 83%) as colorless crystals.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07652133B2 |
| 출처 데이터셋 | uspto-grants-2010_01 |
| ORD ID | ord-118e0c154ca845e29829a6f936038e57 |
| 출처 메모 | uspto-grants-2010_01 |